Human epidermal growth factor receptor 2 (Her2) testing for uterine serous carcinoma: Report of scenarios of unusual overexpression

The human epidermal growth factor receptor 2 (Her2) is tested in many human cancers, including breast, bladder, pancreatic, ovarian and stomach. The American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) have issued Clinical Practice Guidelines for reporting Her2 results...

Descripción completa

Detalles Bibliográficos
Autores principales: Quddus, M. Ruhul, Hansen, Katrine, Tantravahi, Umadevi, Sung, C. James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103767/
https://www.ncbi.nlm.nih.gov/pubmed/32258332
http://dx.doi.org/10.1016/j.gore.2020.100561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103767/
https://www.ncbi.nlm.nih.gov/pubmed/32258332
http://dx.doi.org/10.1016/j.gore.2020.100561

Ejemplares similares